CURRENT R&D

The future depends on what we do today

We are actively researching several therapies that aim to change the face of clinical care. INOMAX^® (nitric oxide) for inhalation is our first agent dedicated to improving the care of critically ill patients, but it’s only the start (see our pipeline).

Read more about our scientific endeavors in our Research & Development section.